IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1852 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed7432    
    Printed223    
    Emailed21    
    PDF Downloaded575    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 

 RESEARCH PAPER
Year : 2006  |  Volume : 38  |  Issue : 3  |  Page : 181-184

Analgesic activity of venlafaxine and its interactions with tramadol, celecoxib and amlodipine in mice


1 Department of Pharmacology, P D U Medical College, Rajkot, India
2 Department of Pharmacology, Medical College, Baroda, India

Correspondence Address:
P K Jha
Department of Pharmacology, P D U Medical College, Rajkot
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.25804

Rights and Permissions

Objective: To study the analgesic activity of venlafaxine and its interactions with tramadol, celecoxib and amlodipine. Materials and Methods: Antinociceptive action of venlafaxine (5, 7.5, 10 and 22.5 mg/kg) was studied in mice (tail flick and writhing tests). Sub-analgesic doses of venlafaxine, tramadol, celecoxib and amlodipine were obtained using these methods. A sub-analgesic dose of venlafaxine was combined with sub-analgesic doses of tramadol, celecoxib and amlodipine to study their interactions. Results: The antinociceptive action of venlafaxine was found only at higher doses (10 and 22.5 mg/kg). When a sub-analgesic dose of venlafaxine was combined with sub-analgesic doses of tramadol, amlodipine or celecoxib, the combination resulted in a significant antinociceptive effect. Conclusion: Evidence of analgesic activity, as indicated by increase in tail flick latency and decrease in number of writhing movements following venlafaxine treatment, suggests that it could possibly have central as well as peripheral action. The findings indicate that the potential use of venlafaxine in antidepressant dose could produce marked pain relief. Thus patients of depression, who are on venlafaxine, may be able to tolerate mild to moderate pain without any additional analgesic.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow